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the relationship between atrial fibrillation (AF) and
pulmonary embolism (PE).1 Our article describes a
significant increase in the rate of hospital admissions
with a primary diagnosis of PE across all age groups
from 2000 to 2015, but we did not report the incidence
of AF in this population. The authors suggest that AF is
not only associated with PE but is also a causal factor
due to right atrial appendage (RAA) thrombus
embolization to the lung, analogous to the relationship
between left atrial appendage (LAA) thrombus and
embolic stroke.
Although the relation between LAA thrombus and
stroke has been rigorously studied, and there are data
showing that LAA is often found in patients with acute
stroke, the mechanism remains an active area of study.2
By comparison, there are few data regarding the relation
of RAA thrombus and PE. To determine that a causal
relation exists, data documenting RAA thrombus in
patients with acute PE are necessary.
The evidence provided by Dr Yetkin and colleagues
suggests that regional coagulation factors in the RAA
may contribute to the increased risk of PE in patients
with AF.3,4 However, these studies were completed in
patients with mitral stenosis and aimed to assess
thrombus formation in the LAA. The effects of mitral
stenosis on the right atrium are poorly understood. Also,
AF does not confer the same risk of thrombus in the
RAA as in the LAA, as the incidence of RAA thrombus
is much lower than that of LAA thrombus
(0.73% vs 9.3%, respectively; P < .01).5
The incidence of AF in our population increased slightly
during the study period (from 10% to approximately
12%) (Fig 1).1 However, patients with AF represent a
small minority of patients admitted with PE. Although
AF may have a small role in PE via formation of RAA
thrombus, we believe that it is more likely that AF and
PE are comorbid conditions associated with similar risk
factors. Specifically, older patients with more
comorbidities are at risk of both diseases. As shown by
Dr Yetkin and colleagues, the CHA2DS2-Vasc
(congestive heart failure, hypertension, age $ 75 years,
diabetes mellitus, stroke/transient ischemic attack,
vascular disease, age 65-74 years, sex category [female])
score is directly associated with incidence of PE. This
indicates that patients with more comorbidities are at
higher risk of PE, and all components of the CHA2DS2-
Vasc score are included in the Elixhauser comorbidity
index used in our study. We do agree with the authorschestjournal.orgthat more study is needed regarding the complex
relation between AF and PE.
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To the Editor:
We read with great interest the paper by Drager et al1
in the June 2019 issue of CHEST regarding the
interactive dynamics between OSA and short sleep
duration (SSD) on one hand, and sleepiness and
cardiometabolic risk on the other. The associations
identified in this large cohort would suggest that a
priori daytime sleepiness is more likely driven by
restricted sleep duration, whereas cardiometabolic risk1273
indicators seemed to be exclusively associated with
OSA. These findings are somewhat in contradiction
with many other epidemiological and interventional
studies (reviews supporting contradictory findings on
both issues are given elsewhere2,3). Notwithstanding,
Drager et al1 have neglected to assess a key mediator
with a demonstrated significant impact on such
important interactions, namely the circadian timing
system (CTS). The CTS is critically involved in
mediating physiological regulatory mechanisms of both
alertness/sleepiness and cardiometabolic function, and
is also often affected in OSA and in patients with
SSD.4,5 For example, although a delayed circadian clock
may lead to shortened sleep, and consequently affect
sleepiness and some other executive functions, it was
recently shown that SSD, later bedtimes, and delayed
circadian timing of sleep were significantly associated
with insulin resistance.6 Circadian disruption and
circadian misalignment can also play an important
role in the link between OSA and cardiometabolic
risk, and they interact with both intermittent
hypoxia and sleep fragmentation to coactivate
shared pathways underlying end-organ
morbidity, such as inflammation and autonomic
dysregulation.
It is also noteworthy that SSD could differently affect the
outcomes of interest as enunciated by the authors,1
depending on which particular sleep stage is
predominantly suppressed or restricted in OSA, as non-
rapid eye movement sleep and rapid eye movement
sleep stages have distinct, albeit complementary,
functions in sleep, sleepiness, and cardiometabolic
functions. Thus, the omission of any circadian clock
measures along with the absence of interventional
components by Drager et al1 precludes any more
definitive insights into their interesting and certainly
provocative findings.
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To the Editor:
We appreciated the interest and comments provided by
Drs Meira e Cruz and Gozal regarding our publication
in CHEST (June 2019) addressing the associations of
OSA, short sleep duration (SSD), and their interactions
on sleepiness and cardiometabolic risk factors.1 Drs
Meira e Cruz and Gozal noted that our results on the
potential consequences of SSD are not consistent with
previous literature. The supported review articles
comprised evidence based on subjective sleep duration.
It is noteworthy that the vast majority of the original
articles quoted in the reviews addressed morbidity and
mortality of SSD, disregarding circadian clock or the
presence of OSA. We can argue that our results are
consistent with recent evidence using objective data. For
instance, at least three studies found no associations
between sleep duration with weight gain or
cardiovascular risk factors.2-4 We are not claiming that
SSD is an innocent bystander, but we share the opinion
that it is time to stop using subjective sleep duration and
to consider OSA as a major confounding factor. Indeed,
our study found that subjects with OSA had a higher
frequency of SSD than participants without OSA.1
Subjective sleep duration has critical limitations. We
have data (in preparation) from the same cohort
showing that approximately 40% of participants have
significant sleep duration misperceptions when
subjective data were compared with objective data.
We agree with the criticism that our study has a cross-
sectional design, and we clearly reported this limitation in
the discussion section.1 Definitive evidence impose[ 1 5 6 # 6 CHE ST D E C EM B E R 2 0 1 9 ]
